Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice.
The aim of the present study was to investigate the short- and long-term effects of a high-fat Western diet (WD) on intake, storage, expenditure, and fecal loss of energy as well as effects on locomotor activity and thermogenesis. WD for only 24 h resulted in a marked physiological shift in energy homeostasis, including increased body weight gain, body fat, and energy expenditure (EE) but an acutely lowered locomotor activity. The acute reduction in locomotor activity was observed after only 3-5 h on WD. The energy intake and energy absorption were increased during the first 24 h, lower after 72 h, and normalized between 7 and 14 days on WD compared with mice given chow diet. Core body temperature and EE was increased between 48 and 72 h but normalized after 21 days on WD. These changes paralleled plasma T(3) levels and uncoupling protein-1 expression in brown adipose tissue. After 21 days of WD, energy intake and absorption, EE, and body temperature were normalized. In contrast, the locomotor activity was reduced and body weight gain was increased over the entire 21-day study period on WD. Calculations based on the correlation between locomotor activity and EE in 2-h intervals at days 21-23 indicated that a large portion of the higher body weight gain in the WD group could be attributed to the reduced locomotor activity. In summary, an acute and persisting decrease in locomotor activity is most important for the effect of WD on body weight gain and obesity in mice.
Bjursell
Mikael
M
AstraZeneca R&D Mölndal, Mölndal, Sweden. mikael.bjursell@astrazeneca.com
Gerdin
Anna-Karin
AK
Lelliott
Christopher J
CJ
Egecioglu
Emil
E
Elmgren
Anders
A
Törnell
Jan
J
Oscarsson
Jan
J
Bohlooly-Y
Mohammad
M
D000818:Animals; D001095:Arachidonic Acids / Q000097:blood; D001823:Body Composition / Q000502:physiology; D001831:Body Temperature / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D002153:Calorimetry, Indirect; D002791:Cholesterol, Dietary / Q000009:adverse effects; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D004032:Diet / Q000009:adverse effects*; D004042:Dietary Fats, Unsaturated / Q000009:adverse effects; D004298:Dopamine / Q000378:metabolism; D063388:Endocannabinoids; D002149:Energy Intake / Q000502:physiology; D004734:Energy Metabolism / Q000502:physiology; D005227:Fatty Acids / Q000009:adverse effects; D005243:Feces / Q000737:chemistry; D006706:Homeostasis / Q000502:physiology; D006728:Hormones / Q000097:blood; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity / Q000502:physiology*; D009765:Obesity / Q000209:etiology* / Q000503:physiopathology; D053284:Polyunsaturated Alkamides / Q000097:blood; D012313:RNA / Q000096:biosynthesis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction
D001095:Arachidonic Acids; D002791:Cholesterol, Dietary; D018076:DNA, Complementary; D004042:Dietary Fats, Unsaturated; D063388:Endocannabinoids; D005227:Fatty Acids; D006728:Hormones; D053284:Polyunsaturated Alkamides; D012313:RNA; C078814:anandamide; D004298:Dopamine